Amgen Says FDA Completes Review Of SNDA Seeking Full Approval For LUMAKRAS

Amgen's Bkemv Approved As First Interchangeable Biosimilar To Soliris

The U.S. Food and Drug Administration has approved Amgen Inc.'s Bkemv (eculizumab-aeeb) as the first interchangeable biosimilar to Soliris (eculizumab), developed by British drug major AstraZeneca's Rare Disease unit Alexion Pharmaceuticals, to treat certain rare diseases. Soliris is a medicine used to treat adults and children with paroxysmal nocturnal haemoglobinuria or PNH...

RTTNews | 343 दिनों पहले

Amgen To Open Manufacturing Site In Central Ohio; To Offer 400 Full-time Jobs

Amgen, Inc. (AMGN) announced Monday the opening of its manufacturing site in Central Ohio, the newest in its global operations network and the most advanced facility to date.

RTTNews | 437 दिनों पहले

Amgen, Horizon Therapeutics Reach Settlement On FTC Lawsuit; Seeks To Close Acquisition In Q4

Amgen (AMGN) and Horizon Therapeutics plc (HZNP) announced Friday the entry into a consent order agreement with the Federal Trade Commission (FTC) that resolves the pending FTC administrative lawsuit. This clears the path to take the final steps to close Amgen's $27.8 billion acquisition of Horizon.

RTTNews | 615 दिनों पहले

Amgen Announces Positive Top-line Results From Phase 3 DAHLIA Study Of ABP 959

Amgen, Inc. (AMGN) announced Tuesday positive top-line results from the DAHLIA study, a randomized, double-blind, active-controlled, two-period crossover Phase 3 study evaluating the efficacy and safety of ABP 959, a biosimilar candidate to SOLIRIS (eculizumab), compared with SOLIRIS in adult patients with paroxysmal nocturnal hemoglobinuria (PNH).

RTTNews | 989 दिनों पहले

Swiss Franc Falls Against U.S. Dollar, Pound

The Swiss franc dropped against the U.S. dollar and the pound in the New York session on Thursday.

RTTNews | 1घंटे 14 मिनट पहले

Euro Weakens Against Some Majors

The euro dropped against some of major counterparts in the New York session on Thursday.

RTTNews | 2घंटे 0 मिनट पहले

Swiss Market Ends Moderately Lower

After a positive start and a subsequent mild setback, the Switzerland market recovered and stayed firm till a little past mid afternoon on Thursday, but turned weak and ended the day's session moderately lower. Investors digested the monetary policy moves of the Federal Reserve and the Bank of England, and reports about the U.S. and the U.K. striking a trade deal.

RTTNews | 3घंटे 8 मिनट पहले

European Stocks Close On Firm Note On Easing Trade Tensions

European stocks closed on a firm note on Thursday with investors reacting to earnings, and news about an impending trade deal between the U.S. and the U.K., and digesting the Bank of England and the Federal Reserve's monetary policy moves.

RTTNews | 3घंटे 29 मिनट पहले

EURUSD	1.12271	GBPUSD	1.32458	AUDUSD	0.64011
USDJPY	145.847	USDCAD	1.39209	USDCHF	0.8318

Advertisement

Amgen Says FDA Completes Review Of SNDA Seeking Full Approval For LUMAKRAS